Avecho Biotechnology Ltd - Waking the sleeping giant

229 Views25 Aug 2025 07:00

Issuer-paid

SUMMARY

Avecho Biotechnology Limited (ASX:AVE) is an Australian biotech company focused on enhancing drug absorption through its proprietary TPM (Tocopheryl Phosphate Mixture).
AVE is currently focusing its efforts on a CBD (cannabidiol) soft-gel capsule for treating insomnia.
AVE is currently undergoing a pivotal Phase III clinical trial of the drug with the potential to be the first over-the-counter (OTC) CBD sleep aid approved by Australia’s Therapeutic Goods Administration (TGA), meaning the drug could be purchased directly and easily at a pharmacy without any prescription required from a doctor.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream